Skip to main content
SpringerLink
Log in

Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion

  • Experimental
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

We previously showed that infusing rats with a solution of ethyl pyruvate ameliorates intestinal mucosal injury after mesenteric ischemia and reperfusion. Ethyl pyruvate also has been shown to inhibit the expression of various pro-inflammatory cytokines in several animal models of critical illness, but dose-response relationships have not been investigated.

Design

Anesthetized C57BL/6 mice were subjected to 60 min of mesenteric ischemia followed by 60 min of reperfusion. After 55 min of ischemia, groups of mice were treated with normal saline or graded bolus doses of ethyl pyruvate dissolved in a calcium-containing balanced salt solution. Some animals (i.e., those in the sham group) were subjected to the anesthetic, but not mesenteric ischemia/reperfusion. Gut mucosal permeability was assessed using an everted gut sac technique.

Setting

University research laboratory.

Measurements and Results

Mesenteric ischemia/reperfusion significantly increased ileal mucosal permeability to the hydrophilic macromolecule, fluorescein isothiocyanate dextran (molecular mass 4,000 Da). Whereas the lowest dose of ethyl pyruvate evaluated (17 mg/kg) had no effect on gut mucosal permeability, the two highest doses tested (50 and 150 mg/kg) significantly ameliorated the development of ischemia/reperfusion-induced mucosal hyperpermeability to about the same extent. The two highest doses of ethyl pyruvate also significantly ameliorated deficits in ileal serosal and mucosal and hepatic surface microvascular perfusion induced by mesenteric ischemia/reperfusion. Ethyl pyruvate inhibited post-ischemia/reperfusion hepatic NF-κB activation and TNF mRNA expression in a dose-dependent fashion.

Conclusion

Doses of ethyl pyruvate equal to or greater than 50 mg/kg ameliorate inflammation, microvascular hypoperfusion and gut mucosal damage induced by mesenteric ischemia/reperfusion in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

References

  1. O'Donnell-Tormey J, Nathan CF, Lanks K, DeBois CJ, de la Harpe J (1987) Secretion of pyruvate. An antioxidant defense of mammalian cells. J Exp Med 165:500–514

    CAS  PubMed  Google Scholar 

  2. Holleman MAF (1904) Notice sur l'action de l'eau oxygénée sur les acétoniques et sur le dicétones 1.2. Recl Trav Chim Pays-bas Belg 23:169–171

  3. Adickes F, Andresen G (1943) Zur kenntnis der reihe der normalen aliphatischen b-oxysauren und der a-ketosauren. Ann Chem 50:41–57

    Google Scholar 

  4. Bunton CA (1949) Oxidation of a-diketones and a-keto-acids by hydrogen peroxide. Nature 163:144

    Google Scholar 

  5. Melzer E, Schmidt H (1988) Carbon isotope effects on the decarboxylation of carboxylic acids. Biochem J 252:913–915

    CAS  PubMed  Google Scholar 

  6. Salahudeen AK, Clark EC, Nath KA (1991) Hydrogen peroxide-induced renal injury. A protective role for pyruvate in vitro and in vivo. J Clin Invest 88:1886–1893

    CAS  PubMed  Google Scholar 

  7. Bunger R, Mallet RT, Hartman DA (1989) Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure. Eur J Biochem 180:221–233

    CAS  PubMed  Google Scholar 

  8. Cicalese L, Lee K, Schraut W, Watkins S, Borle A, Stanko R (1999) Pyruvate prevents ischemia-reperfusion mucosal injury of rat small intestine. Am J Surg 171:97–100

    Article  Google Scholar 

  9. Sileri P, Schena S, Morini S, Rastellini C, Pham S, Benedetti E, Cicalese L (2001) Pyruvate inhibits hepatic ischemia-reperfusion injury in rats. Transplantation 72:27–30

    CAS  PubMed  Google Scholar 

  10. Gupta SK, Mohanty I, Trivedi D, Tandon R, Srivastava S, Joshi S (2002) Pyruvate inhibits galactosemic changes in cultured cat lens epithelial cells. Ophthalmic Res 34:23–28

    Article  CAS  PubMed  Google Scholar 

  11. Zhao W, Devamanoharan PS, Henein M, Ali AH, Varma SD (2000) Diabetes-induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab 2:165–174

    Article  CAS  PubMed  Google Scholar 

  12. Lee JY, Kim YH, Koh JY (2001) Protection by pyruvate against transient forebrain ischemia in rats. J Neurosci 21:1–6

    Google Scholar 

  13. Slovin PN, Huang CJ, Cade JR, Wood CE, Nasiroglu O, Privette M, Orbach P, Skimming JW (2001) Sodium pyruvate is better than sodium chloride as a resuscitation solution in a rodent model of profound hemorrhagic shock. Resuscitation 50:109–115

    Article  CAS  PubMed  Google Scholar 

  14. Varma SD, Devamanoharan PS, Rutzen AR, Ali AH, Henein M (1999) Attenuation of galactose-induced cataract by pyruvate. Free Rad Res 30:253–263

    CAS  Google Scholar 

  15. Zhao W, Devamanoharan PS, Varma SD (2000) Fructose induced deactivation of antioxidant enzymes: preventive effect of pyruvate. Free Rad Res 33:23–30

    CAS  Google Scholar 

  16. Varma SD, Devamanoharan PS, Ali AH (1998) Prevention of intracellular oxidative stress to lens by pyruvate and its ester. Free Rad Res 28:131–135

    CAS  Google Scholar 

  17. Montgomery CM, Webb JL (1956) Metabolic studies on heart mitochondria. II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. J Biol Chem 221:359–368

    CAS  Google Scholar 

  18. Montgomery CM, Fairhurst AS, Webb JL (1956) Metabolic studies on heart mitochondria. III. The action of parapyruvate on a-ketoglutaric oxidase. J Biol Chem 221:369–376

    CAS  Google Scholar 

  19. Willems JL, de Kort AFM, Vree TB, Trijbels JMF, Veerkamp JH, Monnens LAH (1978) Non-enzymatic conversion of pyruvate in aqueous solution to 2,4-dihydroxy-2-methylglutaric acid. Febs Lett 86:42–44

    Article  CAS  PubMed  Google Scholar 

  20. Margolis SA, Coxon B (1986) Identification and quantitation of the impurities in sodium pyruvate. Anal Biochem 58:2504–2510

    CAS  Google Scholar 

  21. Sims CA, Wattanasirichaigoon S, Menconi MJ, Ajami AM, Fink MP (2001) Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit Care Med 29:1513–1518

    CAS  PubMed  Google Scholar 

  22. Yang R, Gallo DJ, Baust JJ, Uchiyama T, Watkins SK, Delude RL, Fink MP (2002) Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 283: G212-G22

    CAS  PubMed  Google Scholar 

  23. Tawadrous ZS, Delude RL, Fink MP (2002) Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17:473–477

    PubMed  Google Scholar 

  24. Venkataraman R, Kellum JA, Song M, Fink MP (2002) Resuscitation with Ringer's ethyl pyruvate solution prolongs survival and modulates plasma cytokine and nitrite/nitrate concentrations in a rat model of lipopolysaccharide-induced shock. Shock 18: 507–512

    PubMed  Google Scholar 

  25. Ulloa L, Ochani M, Yang H, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 99:12351–12356

    Article  CAS  PubMed  Google Scholar 

  26. Wattanasirichaigoon S, Menconi MJ, Delude RL, Fink MP (1999) Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats. Shock 12:127–133

    CAS  PubMed  Google Scholar 

  27. Sappington PL, Han X, Yang R, Delude RL, Fink MP (2003) Ethyl pyruvate ameliorates intestinal epithelial barrier dysfunction in endotoxemic mice and immunostimulated Caco-2 enterocytic monolayers. J Pharmacol Exp Ther 304:464–476

    Article  CAS  PubMed  Google Scholar 

  28. Mertz RJ, Worley JFI, Spencer B, Johnson JH, Dukes ID (1996) Activation of stimulus-secretion coupling in pancreatic b-cells by specific products of glucose metabolism. J Biol Chem 271:4838–4845

    CAS  PubMed  Google Scholar 

  29. Zawalich WS, Zawalich KC (1997) Influence of pyruvic acid methyl ester on rat pancreatic islets. Effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell. J Biol Chem 272:3527–3531

    Article  CAS  PubMed  Google Scholar 

  30. Lembert N, Joos HC, Idahl L-Å, Ammon HPT, Wahl MA (2001) Methyl pyruvate initiates membrane depolarization and insulin release by metabolic factors other than ATP. Biochem J 354:345–350

    Article  PubMed  Google Scholar 

  31. Fox ES, Cantrell CH, Leingang KA (2003) Inhibition of the Kupffer cell inflammatory response by acute ethanol: NF-kappa B activation and subsequent cytokine production. Biochem Biophys Res Comm 225:134–140

    Article  Google Scholar 

  32. Jonsson AS, Palmblad JE (2001) Effects of ethanol on NF-kappaB activation, production of myeloid growth factors, and adhesive events in human endothelial cells. J Infect Dis 184:761–769

    Article  CAS  PubMed  Google Scholar 

  33. Roman J, Colell A, Blasco C, Caballeria J, Pares A, Rodes J, Fernandez-Checa JC (1999) Differential role of ethanol and acetaldehyde in the induction of oxidative stress in HEP G2 cells: effect on transcription factors AP-1 and NF-kappaB. Hepatology 30:1473–1480

    CAS  PubMed  Google Scholar 

  34. Boyd AJ, Sherman IA, Saibil FG (1994) Intestinal microcirculation and leukocyte behavior in ischemia-reperfusion injury. Microvasc Res 47:355–368

    Article  CAS  PubMed  Google Scholar 

  35. Han JY, Miura S, Akiba Y, Higuchi H, Kato S, Suzuki H, Yokoyama H, Ishii H (2001) Chronic ethanol consumption exacerbates microcirculatory damage in rat mesentery after reperfusion. Am J Physiol Gastrointest Liver Physiol 280: G939-G948

    CAS  PubMed  Google Scholar 

  36. Hu S, Sheng ZY (2002) The effects of anisodamine and dobutamine on gut mucosal blood flow during gut ischemia/ reperfusion. World J Gastroenterol 8:555–557

    CAS  PubMed  Google Scholar 

  37. Sato A, Kuwabara Y, Sugiura M, Seo Y, Fujii Y (1999) Intestinal energy metabolism during ischemia and reperfusion. J Surg Res 82:261–267

    Article  CAS  PubMed  Google Scholar 

  38. Almond NE, Wheatley AM (1992) Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am J Physiol 262: G203-G209

    CAS  PubMed  Google Scholar 

  39. Yamagishi Y, Horie Y, Kato S, Kajihara M, Tamai H, Granger DN, Ishii H (2002) Ethanol modulates gut ischemia/reperfusion-induced liver injury in rats. Am J Physiol Gastrointest Liver Physiol 282: G640-G646

    CAS  PubMed  Google Scholar 

  40. Rahat MA, Lahat N, Smollar J, Brod V, Kinarty A, Bitterman H (2001) Divergent effects of ischemia/reperfusion and nitric oxide donor on TNFalpha mRNA accumulation in rat organs. Shock 15:312–317

    CAS  PubMed  Google Scholar 

  41. Mentzer RMJr, Van Wylen DG, Sodhi J, Weiss RJ, Lasley RD, Willis J, Bunger R, Flint LM (1989) Effect of pyruvate on regional ventricular function in normal and stunned myocardium. Ann Surg 209:629–633

    PubMed  Google Scholar 

  42. Hermann HP, Zeitz O, Keweloh B, Hasenfuss G, Janssen PM (2000) Pyruvate potentiates inotropic effects of isoproterenol and Ca(2+) in rabbit cardiac muscle preparations. Am J Physiol Heart Circ Physiol 279: H702-H708

    CAS  PubMed  Google Scholar 

  43. Hermann HP, Pieske B, Schwarzmuller E, Keul J, Just H, Hasenfuss G (1999) Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Lancet 353:1321–1323

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowlegements

This study was made possible by a grant from DARPA (N65236-00-1-5434) and NIH grants GM58484 and GM37631.

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Takashi Uchiyama, Russell L. Delude & Mitchell P. Fink

  2. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Russell L. Delude

  3. Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

    Mitchell P. Fink

Authors
  1. Takashi Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Russell L. Delude
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mitchell P. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitchell P. Fink.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uchiyama, T., Delude, R.L. & Fink, M.P. Dose-dependent effects of ethyl pyruvate in mice subjected to mesenteric ischemia and reperfusion. Intensive Care Med 29, 2050–2058 (2003). https://doi.org/10.1007/s00134-003-1966-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1966-x

Keywords

Search

Navigation